<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to polymyalgia rheumatica - inflammatory condition causing muscle pain and stiffness in older adults.">
    <meta name="keywords" content="polymyalgia rheumatica, PMR, muscle stiffness, inflammatory condition, shoulder hip pain">
    <title>Polymyalgia Rheumatica | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Polymyalgia Rheumatica</h1><p>Inflammatory condition affecting shoulders and hips</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Polymyalgia Rheumatica?</h2>
                <p>Polymyalgia rheumatica (PMR) is an inflammatory disorder causing muscle pain and stiffness, especially in the shoulders and hips. It almost exclusively affects people over 50 and responds dramatically to low-dose corticosteroids.<sup>1</sup></p>

                <h2>Symptoms<sup>2</sup></h2>
                <ul>
                    <li>Pain and stiffness in shoulders, upper arms</li>
                    <li>Pain and stiffness in hips, thighs</li>
                    <li>Stiffness worse in morning (&gt;45 minutes)</li>
                    <li>Difficulty raising arms above shoulders</li>
                    <li>Difficulty getting out of chair</li>
                    <li>Fatigue</li>
                    <li>General malaise</li>
                    <li>Sometimes low-grade fever</li>
                </ul>

                <h2>Risk Factors</h2>
                <ul>
                    <li>Age &gt;50 (average 70)</li>
                    <li>Women more than men</li>
                    <li>Northern European ancestry</li>
                </ul>

                <h2>Diagnosis</h2>
                <ul>
                    <li>Elevated inflammatory markers (ESR, CRP)</li>
                    <li>Typical clinical presentation</li>
                    <li>Dramatic response to steroids</li>
                    <li>Exclude other conditions</li>
                    <li>Ultrasound may show bursitis</li>
                </ul>

                <h2>Giant Cell Arteritis Association</h2>
                <ul>
                    <li>15-20% of PMR patients develop GCA</li>
                    <li>Watch for: new headache, jaw pain, vision changes</li>
                    <li>GCA is medical emergency (risk of blindness)</li>
                </ul>

                <h2>Treatment<sup>3</sup></h2>
                <h3>Corticosteroids (Mainstay)</h3>
                <ul>
                    <li>Low-dose prednisone (15-20mg initially)</li>
                    <li>Rapid improvement (often within days)</li>
                    <li>Gradual taper over 1-2 years</li>
                    <li>Some need longer treatment</li>
                </ul>

                <h3>Managing Steroid Side Effects</h3>
                <ul>
                    <li>Calcium and vitamin D</li>
                    <li>Bone density monitoring</li>
                    <li>Blood sugar monitoring</li>
                    <li>Weight management</li>
                </ul>

                <h2>Prognosis</h2>
                <ul>
                    <li>Usually self-limited (1-5 years)</li>
                    <li>Excellent response to treatment</li>
                    <li>Some have relapses</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. <em>Lancet</em>. 2008;372(9634):234-245.</li>
                    <li>Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 provisional classification criteria for polymyalgia rheumatica. <em>Arthritis Rheum</em>. 2012;64(4):943-954.</li>
                    <li>Dejaco C, Singh YP, Perel P, et al. 2015 recommendations for the management of polymyalgia rheumatica. <em>Arthritis Rheumatol</em>. 2015;67(10):2569-2580.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
